{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:23:24Z","timestamp":1760189004864,"version":"3.33.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[1991,10,1]],"date-time":"1991-10-01T00:00:00Z","timestamp":686275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1991,10,1]],"date-time":"1991-10-01T00:00:00Z","timestamp":686275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1991,10]]},"DOI":"10.1136\/ard.50.10.706","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"706-709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Serum soluble interleukin 2 receptor in systemic lupus erythematosus: effects of disease activity and infection."],"prefix":"10.1016","volume":"50","author":[{"given":"K.L","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.P","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/rhe1.1971.17.issue-1-4.06","article-title":"Immunological reactivity in patients with systemic lupus erythematosus: hormonal antibody and cellular immune responses","volume":"17","author":"Abe, T.; Homura, M.","year":"1971","unstructured":"Abe T, Homura M. Immunological reactivity in patients with systemic lupus erythematosus: hormonal antibody and cellular immune responses. Acta Rheumatologica Scandinavica 1971; 17: 35-41.","journal-title":"Acta Rheumatologica Scandinavica"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1172\/JCI109948","article-title":"Alternations in immunoregulatory T cell subsets in active systemic lupus erythematosus","volume":"66","author":"Morimoto, C.; L, Reinherz E.; F, Schlossman S.; H, Schur P.; A, MiRls J.; D, Steinberg A.","year":"1980","unstructured":"Morimoto C, Reinherz E L, Schlossman S F, Schur P H, MiRls J A, Steinberg A D. Alternations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest 1980; 66: 1171-4.","journal-title":"J Clin Invest"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.130.6.2651","article-title":"Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus","volume":"130","author":"Linher-Israeli-M, Baltka A.C.; C, Kitridon R.; S, Gendler; S, Gillis; A, Horwitz D.","year":"1983","unstructured":"Linher-Israeli-M, Baltka A C, Kitridon R C, Gendler S, Gillis S, Horwitz D A. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus. J Immunol 1983; 130: 2651-5.","journal-title":"J Immunol"},{"key":"ref_4","first-page":"93","article-title":"T and B lymphocytic function in patients with lupus nephritis: correlation with renal pathology","volume":"21","author":"E, Balow J.; C, Tsoko G.","year":"1984","unstructured":"Balow J E, Tsoko G C. T and B lymphocytic function in patients with lupus nephritis: correlation with renal pathology. Clin Nephrol 1984; 21: 93-7.","journal-title":"Clin Nephrol"},{"key":"ref_5","first-page":"3172","article-title":"Soluble interleukin 2 receptors are released from activated human lymphoid cell in vitro","volume":"13","author":"A, Rubin L.; C, Kurman C.; E, Fritz M.","year":"1985","unstructured":"Rubin L A, Kurman C C, Fritz M E, et al. Soluble interleukin 2 receptors are released from activated human lymphoid cell in vitro. J Immunol 1985; 13S: 3172-7. Serum soluble interleukin 2 receptor in SLE","journal-title":"J Immunol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/eji.1830160426","article-title":"Interleukin 2 receptors are released by cells in vitro and in vivo. I. detection of soluble IL2 receptors in cell culture supernatants and in the serum of mice by immunoradiometric assay","volume":"16","year":"1986","unstructured":"Osawa H, Josimovic-Alasevic 0, Diamatstein T. Interleukin 2 receptors are released by cells in vitro and in vivo. I. detection of soluble IL2 receptors in cell culture supernatants and in the serum of mice by immunoradiometric assay. EurJ Immunol 1986; 16: 467-9.","journal-title":"EurJ Immunol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF00916949","article-title":"Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"8","author":"Semenzato, G.; M, Bambara L.; Biasis, D.","year":"1988","unstructured":"Semenzato G, Bambara L M, Biasis D, et al. Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. J Clin Immunol 1988; 8: 447-52.","journal-title":"J Clin Immunol"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/art.1780310605","article-title":"Soluble interleukin-2 receptors in systemic lupus erythematosus","volume":"31","author":"E, Wolf R.; G, Brelsford W.","year":"1988","unstructured":"Wolf R E, Brelsford W G. Soluble interleukin-2 receptors in systemic lupus erythematosus. Arthritis Rheum 1988; 31: 729-35.","journal-title":"Arthritis Rheum"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/art.1780311103","article-title":"Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation","volume":"31","author":"H, Campen D.; A, Horwitz D.; P, Jr, Quismorio F.; R, Ehresmann G.; J, Martin W.","year":"1988","unstructured":"Campen D H, Horwitz D A, Quismorio F P Jr, Ehresmann G R, Martin W J. Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis Rhewn 1988; 31: 1358-64.","journal-title":"Arthritis Rhewn"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/art.1780310704","article-title":"soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis","volume":"31","author":"C, Keystone E.","year":"1988","unstructured":"Keystone E C, Snow K M, Bombradier C, Chang C H, Nelson D L, Rubin L A. Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis. Arthritis Rhewn 1988; 31: 844-9.","journal-title":"Arthritis Rhewn"},{"key":"ref_11","first-page":"171","article-title":"Interleukin-2 receptor levels are increased in blood of heart transplant patients during infections","volume":"5","author":"Stoic, V.; R, Krause J.","year":"1987","unstructured":"Stoic V, Krause J R. Interleukin-2 receptor levels are increased in blood of heart transplant patients during infections. Diagnostic Clinical Immunology 1987; 5: 171-4.","journal-title":"Diagnostic Clinical Immunology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1200\/JCO.1987.5.8.1262","article-title":"Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival","volume":"5","author":"K, Wagner D.; J, Kiwanka; K, Edwards B.; A, Rubin L.; L, Nelson D.; T, Magrath I.","year":"1987","unstructured":"Wagner D K, Kiwanka J, Edwards B K, Rubin L A, Nelson D L, Magrath I T. Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival. J Clin Oncol 1987; 5: 1262-74.","journal-title":"J Clin Oncol"},{"key":"ref_13","first-page":"597","article-title":"Soluble interleukin2 receptors in patients with malignant lymphoma","volume":"112","author":"S, Harrington D.; C, Patel I.; K, Lai P.","year":"1988","unstructured":"Harrington D S, Patel I C, Lai P K, et al. Soluble interleukin2 receptors in patients with malignant lymphoma. Arch Pathol Lab Med 1988; 112: 597-601.","journal-title":"Arch Pathol Lab Med"},{"key":"ref_14","first-page":"1271","article-title":"revised criteria for the clssification of systemic lupus erythematosus","volume":"25","author":"M, Tan E.; S, Cohen A.; F, Fries J.","year":"1982","unstructured":"Tan E M, Cohen A S, Fries J F, et al. The 1982 revised criteria for the clssification of systemic lupus erythematosus. Arthitis Rheum 1982; 25: 1271-7.","journal-title":"The"},{"key":"ref_15","first-page":"893","article-title":"Lupus pregnancy, case control prospective study demonstrating absence of lupus exacerbation during or after pregnancy","volume":"77","author":"D, Lockshin M.; D, Reinitz E.; L, Ruzin M.; M, Murrman; D, Estes","year":"1984","unstructured":"Lockshin M D, Reinitz E D, Ruzin M L, Murrman M, Estes D. Lupus pregnancy, case control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. AmJ Med 1984; 77: 893-8.","journal-title":"AmJ Med"},{"key":"ref_16","first-page":"347","article-title":"Signals required for activation and growth of autoimmune T lymphocytes","volume":"1","author":"J, Santoro T.; R, Malek T.; J, Rosenberg Y.; C, Morse H.; D, Steinberg A.","year":"1984","unstructured":"Santoro T J, Malek T R, Rosenberg Y J, Morse H C, Steinberg A D. Signals required for activation and growth of autoimmune T lymphocytes. J Mol CeUl Immunol 1984; 1: 347-56.","journal-title":"J Mol CeUl Immunol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0090-1229(88)80012-6","article-title":"Interleukin-2 receptor expression in peripheral blood lymphocytes from systemic lupus erythematosus patients: relationship to clinical activity","volume":"47","author":"R, Wigfall D.; S, Sakai R.; J, Wallace D.; C, Jordan S.","year":"1988","unstructured":"Wigfall D R, Sakai R S, Wallace D J, Jordan S C. Interleukin-2 receptor expression in peripheral blood lymphocytes from systemic lupus erythematosus patients: relationship to clinical activity. Clin Immunol Immunopathol 1988; 47: 354-62.","journal-title":"Clin Immunol Immunopathol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.4049\/jimmunol.139.4.1070","article-title":"Impaired expression of high affmiity interleukin 2 receptor on activated lymphocytes from patients with systemic lupus erythematosus","volume":"139","author":"Ishida, H.; Kumagai, S.; Umehara, H.","year":"1987","unstructured":"Ishida H, Kumagai S, Umehara H, et al. Impaired expression of high affmiity interleukin 2 receptor on activated lymphocytes from patients with systemic lupus erythematosus. J Immunol 1987; 139: 1070-4.","journal-title":"J Immunol"},{"key":"ref_19","first-page":"3","article-title":"Interleukin 2 receptors and responsiveness to recombinant human interleukin 2 in patients with systemic lupus erythematosus","volume-title":"Mayo Clin Proc","volume":"62","author":"Lakhanpal, S.; S, Handwerger B.","year":"1987","unstructured":"Lakhanpal S, Handwerger B S. Interleukin 2 receptors and responsiveness to recombinant human interleukin 2 in patients with systemic lupus erythematosus. Mayo Clin Proc 1987; 62: 3-7."},{"key":"ref_20","first-page":"\"605A.\" # \"454.\"","article-title":"Elevated score levels of interleukin 2 receptor are present in patients maintained on chronic hemodialysis","volume":"34","author":"Peacocke, M.; Ml, McLaughlin; Levey, A.; A, Pukin L.; L, Nilson D.","year":"1986","unstructured":"Peacocke M, McLaughlin Ml, Levey A, Pukin L A, Nilson D L. Elevated score levels of interleukin 2 receptor are present in patients maintained on chronic hemodialysis [Abstract]. Clin Res 1986; 34: 605A. 22 MacKeen L, Brown M, Ip S H, et al. Serum interleukin 2 receptor as a marker for active T cell malignancy [Abstract]. Fed Proc 1986; 45: 454.","journal-title":"Clin Res; Fed Proc 1986; 45; interleukin 2 receptor as a marker for active T cell malignancy"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.4049\/jimmunol.139.5.1496","article-title":"Elevated titers of cell-free interleukin 2 receptor in serum of lupus mice","volume":"139","year":"1987","unstructured":"Balderas R S, Josimovic-Alasevic 0, Diamantstein T, Dixon F J, Theofilopoulos A N. Elevated titers of cell-free interleukin 2 receptor in serum of lupus mice. J Immunol 1987; 139: 1496-500.","journal-title":"J Immunol"},{"key":"ref_22","first-page":"1053","article-title":"02 Microglobulin and systemic lupus erythematosus","volume":"13","author":"K, Yeung C.; L, Wong K.; S, Wong W.; H, Chan K.","year":"1986","unstructured":"Yeung C K, Wong K L, Wong W S, Chan K H. 02 Microglobulin and systemic lupus erythematosus. J Rheumaol 1986; 13: 1053-8.","journal-title":"J Rheumaol"},{"key":"ref_23","first-page":"291","article-title":"C-reactive protein in the differential diagnosis between infection and disease reactivation in SLE","volume":"8","author":"G, Bravo M.; D, Alarcon-Segovia","year":"1981","unstructured":"Bravo M G, Alarcon-Segovia D. C-reactive protein in the differential diagnosis between infection and disease reactivation in SLE. J Rheumatol 1981; 8: 291-4.","journal-title":"J Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724106061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724106061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.50.10.706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T05:24:03Z","timestamp":1737523443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724106061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1991,10]]}},"alternative-id":["S0003496724106061"],"URL":"https:\/\/doi.org\/10.1136\/ard.50.10.706","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[1991,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum soluble interleukin 2 receptor in systemic lupus erythematosus: effects of disease activity and infection.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.50.10.706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1991 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}